Fidelity Investments
AGTC

Fidelity Investments’s Applied Genetic Technologies Corporation AGTC Stock Holding History

Fidelity Investments’s Portfolio AGTC Stock Details AGTC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-2
Closed – – 5280
2021
Q2 		$0 Buy
+2
New +$8 ﹤0.01% 5110
2021
Q1 		– Sell
-129,100
Closed -$528K – 4711
2020
Q4 		$528K Hold
129,100
– – ﹤0.01% 2634
2020
Q3 		$627K Buy
+129,100
New +$705K ﹤0.01% 2501
2020
Q1 		– Sell
-500
Closed -$2K – 4411
2019
Q4 		$2K Hold
500
– – ﹤0.01% 3602
2019
Q3 		$2K Hold
500
– – ﹤0.01% 3596
2019
Q2 		$2K Buy
500
+250
+100% +$1.02K ﹤0.01% 3565
2019
Q1 		$1K Sell
250
-107
-30% -$374 ﹤0.01% 3540
2018
Q4 		$1K Buy
+357
New +$2.09K ﹤0.01% 3454
2018
Q3 		– Sell
-35,911
Closed -$133K – 3868
2018
Q2 		$133K Sell
35,911
-146,198
-80% -$676K ﹤0.01% 2599
2018
Q1 		$701K Sell
182,109
-108,421
-37% -$456K ﹤0.01% 2483
2017
Q4 		$1.05M Sell
290,530
-191,751
-40% -$724K ﹤0.01% 2445
2017
Q3 		$1.91M Sell
482,281
-186,379
-28% -$856K ﹤0.01% 2336
2017
Q2 		$3.41M Sell
668,660
-169,037
-20% -$949K ﹤0.01% 2243
2017
Q1 		$5.78M Sell
837,697
-277,797
-25% -$2.17M ﹤0.01% 2141
2016
Q4 		$10.4M Buy
1,115,494
+24,864
+2% +$224K ﹤0.01% 1950
2016
Q3 		$10.7M Sell
1,090,630
-263,600
-19% -$3.56M ﹤0.01% 1962
2016
Q2 		$19.1M Sell
1,354,230
-181,431
-12% -$2.83M ﹤0.01% 1697
2016
Q1 		$21.5M Sell
1,535,661
-222,469
-13% -$3.26M ﹤0.01% 1628
2015
Q4 		$35.9M Buy
1,758,130
+407,334
+30% +$6.28M ﹤0.01% 1394
2015
Q3 		$17.7M Buy
1,350,796
+15,407
+1% +$256K ﹤0.01% 1697
2015
Q2 		$20.5M Hold
1,335,389
– – ﹤0.01% 1722
2015
Q1 		$26.7M Buy
1,335,389
+1,825
+0.1% +$40.8K ﹤0.01% 1618
2014
Q4 		$28M Buy
1,333,564
+577,115
+76% +$11.8M ﹤0.01% 1594
2014
Q3 		$14.1M Buy
756,449
+153,243
+25% +$2.78M ﹤0.01% 1900
2014
Q2 		$13.9M Buy
+603,206
New +$10.6M ﹤0.01% 1949

Other funds holding AGTC

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
IVM
InterWest Venture Management San Francisco, California $20.6M AUM 48.5% 1-Year Est. Return
PCM
Portolan Capital Management Boston, Massachusetts $1.88B AUM 115.74% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return

Fidelity Investments's AGTC Position: Q3 2021 in Review

Fidelity Investments sold out of Applied Genetic Technologies Corporation (AGTC) in Q3 2021, closing a stake of 2 shares.

Fidelity Investments first reported a position in AGTC in Q2 2014 and held it in 25 quarters. The position peaked at $35.9M in Q4 2015. 64 funds tracked by Wall St. Rank hold AGTC as of Q3 2021.

  • Fidelity Investments reported no remaining Applied Genetic Technologies Corporation position as of Q3 2021 after selling out during the quarter.
  • Fidelity Investments sold 2 Applied Genetic Technologies Corporation shares in Q3 2021.
  • Fidelity Investments first reported a position in Applied Genetic Technologies Corporation in Q2 2014 and held it in 25 quarters.
  • Fidelity Investments's Applied Genetic Technologies Corporation position peaked at $35.9M in Q4 2015.
  • 64 funds tracked by Wall St. Rank held Applied Genetic Technologies Corporation as of Q3 2021.

Based on Fidelity Investments's 13F filing for Q3 2021, filed 15 Nov 2021.